Fung: Coagulation II Flashcards
Clinically, most bleeding disorders can be divided into these two categories…
coagulation-type bleeding
platelet-type bleeding
In this type of bleeding disorder, petechiae and mucosal bleeding are rare, but hemarthroses, deep hematomas and delayed bleeding are common; seen in males
coagulation type bleeding disorder
In this type of bleeding disorder, petechiae and mucosal bleeding are common, but hemarthroses, deep hematomas and delayed bleeding are RARE; seen in females
platelet type bleeding disorder
This is the most common inherited bleeding disorder; it is a defect in PLATELET ADHESION; combined platelet and coagulation defect; 4 main types
von Willebrand disease
Where is von Willebrand factor synthesized? Where is it sotred? What does it do?
synthesized in endothelial cells and megakaryocytes; stored in Weibel-Palade bodies of endothelial cells and alpha granules of megakaryocytes; mediates platelet adhesion by binding GPIb
Another name for von Willebrand factor
Ristocetin cofactor
What does vWF complex with in the circulation to decrease its degradation?
factor 8
Most common type and results in a mild bleeding disorder
QUANTITATIVE disorder showing reduced amounts of vWF
Laboratory evaluation will show
Normal PT
Prolonged PTT and BT
Decreased FVIII
Decreased vWF and activity
von Willebrand disease: Type 1
Qualitative (functional) defect of vWF
4 subtypes
IIa
IIb
IIM – rare defect that prevents vWF binding to GPIb
IIN – rare defect with reduced vWF binding to FVIII
von Willebrand disease: Type 2
What is the main difference between von Willebrand disease type IIa and type IIb?
IIa: absence of high molecular weight multimers, ristocetin cofactor (vWF) activity decreased;
IIb: decreased high molecular weight multimers, enhanced ristocetin cofactor, DO NOT give DDAVP
Defect of platelet adhesion
Due to decreased platelet GPIb/V/IX
Patients clinically manifest with thrombocytopenia and giant platelets
Laboratory evaluation
PFT: aggregation on all agonists except ristocetin
Similar picture to vWD on PFT
Peripheral smear will show large platelets (unlike vWD)
Bernard Soulier syndrome
In Bernard Soulier syndrome, platelet adhesion is defective due to a decrease in (blank)
GPIb/V/IX
How can you differentiate von Willebrand disease from Bernard Soulier syndrome?
Bernard Soulier syndrome - giant platelets
Autosomal recessive disorder due to deficient GP IIb/IIIa (fibrinogen receptor)
Platelets lack the PLA1 antigen
Laboratory evaluation
PFT: fail to aggregate with all agonists but ristocetin
Glanzmann thrombasthenia
What is deficient in Glanzmann thromasthenia?
GP IIb/IIIa (fibrinogen receptor)
**platelets don’t have PLA1 antigen
You can also have defects in granules of platelets. In alpha granule disease, aggregation is blunted with all agents except (blank)
ADP
- *one of the components of dense granules
- *associated with gray-platelet syndrome
If you have dense granule disease, you will not get a (blank)
second wave of aggregation
These two drugs can cause excessive bleeding by inhibiting COX-1 (the enzyme involved in thromboxane A2 production)
Aspirin
NSAIDs
**by blocking this enzyme, you will not get dense granule release and the secondary wave of aggregation
Which has a reversible effect, aspririn or NSAIDs?
NSAIDs
What are these? Immune thrombocytopenic purpura (ITP) Thrombotic thrombocytopenic purpura (TTP) Hemolytic uremic syndrome (HUS) Heparin induced thrombocytopenia (HIT)
disorders characterized by thrombocytopenia (low platelets)
Diagnosis of exclusion: healthy patient with isolated thrombocytopenia with no other obvious cause Antigenic target of the antibody varies GP IIb GP IIIa GP Ib GP V
immune thrombocytopenic purpura
**when there is no other cause for the thrombocytopenia, consider this